Table 2.
Proportion of subjects from each group that attain the minimal clinically important change (MCIC) in each and all three of the outcome measures
| MCIC | NS (n = 19) | D (n = 27) | PNS (n = 9) | M (n = 19) | χ2 b | p valueb | 
|---|---|---|---|---|---|---|
| Pain NRS | 11% (n = 2) | 15% (n = 4) | 56% (n = 5) | 16% (n = 3) | 7.29 | 0.057 | 
| GPC | 16% (n = 3) | 33% (n = 9) | 78% (n = 7) | 16% (n = 3) | 12.20 | 0.005 | 
| RMDQ | 67% (n = 12)a | 67% (n = 18) | 89% (n = 8) | 42% (n = 8) | 6.10 | 0.104 | 
| Responder | 11% (n = 2) | 15% (n = 4) | 56% (n = 5) | 11% (n = 2) | 7.98 | 0.031c | 
NS central sensitization, D denervation, PNS peripheral nerve sensitization, M musculoskeletal, NRS numerical rating scale, GPC global perceived change, RMDQ Roland Morris Disability Questionnaire, Responder achieved MCIC in all three of the outcome measures
aMissing data n = 1
bFishers exact test values and p values
cp values for pair-wise comparisons (Fisher’s exact test): NS-PNS: 0.02; D-PNS: 0.026; M-PNS: 0.016. All other pair-wise comparisons were not significant with p > 0.48